Relief to high BP, diabetes and heart patients! Rates of 39 medicines fixed, action will be taken on excess recovery

Medicines can also be sold at fixed rates.

If you take medicines for diseases like high blood pressure (BP), diabetes, heart disease, HIV or eye infection, then there is good news for you. The Central Government has fixed the maximum retail price of 39 essential medicines. This means that now these medicines will not be sold for more than the fixed price.

This decision has been taken by the National Pharmaceutical Pricing Authority (NPPA). According to the notification issued by the Ministry of Chemicals and Fertilizers on July 8, the retail prices of 39 new drug formulations have been fixed under the Drugs (Prices Control) Order (DPCO), 2013. The aim of the government is to make essential medicines more affordable for the common people, so that the cost of treatment for patients can be reduced. These medicines include medicines used in the treatment of serious diseases like high blood pressure, diabetes, heart disease, HIV and eye infections.

See the list of medicines here

What will happen if you charge more money?

The government has clearly said that if any drug manufacturer or marketing company charges more than the fixed price, then it will have to deposit back the excess amount recovered from the customers. Along with this, interest will also have to be paid on it. This action will be taken under the Drugs (Price Control) Order, 2013 and the Obsidian Commodities Act, 1955. That means pharmaceutical companies cannot charge arbitrary prices.

New rule for shopkeepers also

NPPA has also reiterated that all medical stores and drug sellers will have to display the price lists issued by drug companies at a place in their shops where customers can easily see them. With this, people will get correct price information and no shopkeeper will be able to charge more than necessary. The government believes that with this decision, essential medicines will remain within the reach of common people, the cost of treatment will reduce and patients will get relief from paying high prices for medicines.

Read this also- SIP of ₹5,000 or investment of ₹1 lakh? What is the fastest way to make ₹20 lakh?

Mahendra Bhargava

Mahendra Bhargava

Mahendra Bhargava is an experienced business and automobile journalist, actively working in the digital media industry since 2018. Mahendra is currently associated with TV9 Bharatvarsh, where he is working on the latest updates, reviews, exclusive stories and in-depth analysis related to business and automobile. With 5+ years of experience in the automobile and business segments, Mahendra has worked in many reputed media organizations. Mahendra started as a reporter with Navdunia (Dainik Jagran Group) newspaper. He further worked in various roles in digital content creation in ETV Bharat, Dainik Bhaskar, News18 and Zee News.

Read More

google button

Leave a Comment